MarketPeel
Insider Trading Intelligence
Pricing
…
CS

Christopher Ryan Schadel

COEP
CHIEF MARKETING OFFICER · COEPTIS THERAPEUTICS HOLDINGS, INC. · CIK 0001550967
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jun 2026
HOLDINGS NOW
12,674
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Christopher Ryan Schadel. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
2,806——12,674Jun 3, 2026Jun 8, 2026 ↗
Other insiders · COEP
Loading peer insiders…
About this filer
CIK 0001550967
ROLE
Chief Marketing Officer
PRIMARY
COEP
COMPANIES
1
ACTIVE SINCE
Jun 2026
MARKETPEEL · /INSIDER/0001550967DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback